KPRX – kiora pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
Kiora Pharmaceuticals (NASDAQ:KPRX) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Kiora Pharmaceuticals Granted U.S. Patent Covering Additional Formulations for the KIO-100 Family of Anti-Inflammatory Compounds [Yahoo! Finance]
Form SCHEDULE 13G/A KIORA PHARMACEUTICALS Filed by: HIRSCHMAN ORIN
Form SCHEDULE 13G/A KIORA PHARMACEUTICALS Filed by: Nantahala Capital Management, LLC
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.